Search results
From Proteopedia
You searched for Ly294002
There is no page with the exact title "Ly294002". The search results for "Ly294002" are displayed below. You can create a page titled Ly294002 (by clicking on the red link).
For more information about searching Proteopedia, see Help.
Showing below 18 results starting with #1.
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
Article title matches
- Category:Ly294002 (39 bytes)
1: List of pages with the keyword Ly294002
Page text matches
- 1e7v (6,570 bytes)
2: ...osphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin and staurosporine==
24: ...nal change in the catalytic domain. Surprisingly, LY294002 and the lead compound on which it was designed, q...
26: ...osphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine.,Walker ... - 1e7u (6,640 bytes)
2: ...osphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin and staurosporine==
24: ...nal change in the catalytic domain. Surprisingly, LY294002 and the lead compound on which it was designed, q...
26: ...osphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine.,Walker ... - 1e8z (6,812 bytes)
2: ...osphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin and staurosporine==
24: ...nal change in the catalytic domain. Surprisingly, LY294002 and the lead compound on which it was designed, q...
26: ...osphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine.,Walker ... - 1e8w (6,557 bytes)
2: ...osphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin and staurosporine==
24: ...nal change in the catalytic domain. Surprisingly, LY294002 and the lead compound on which it was designed, q...
26: ...osphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine.,Walker ... - 1e90 (6,588 bytes)
2: ...osphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin and staurosporine==
24: ...nal change in the catalytic domain. Surprisingly, LY294002 and the lead compound on which it was designed, q...
26: ...osphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine.,Walker ... - 1e8y (6,640 bytes)
2: ...osphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin and staurosporine==
23: ...nal change in the catalytic domain. Surprisingly, LY294002 and the lead compound on which it was designed, q...
25: ...osphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine.,Walker ... - 1yhs (4,525 bytes)
22: ...Y294002 also inhibits Pim-1, the structure of the LY294002.Pim-1 complex reveals a new binding mode that may...
24: ...echanism of serine/threonine kinase inhibition by LY294002.,Jacobs MD, Black J, Futer O, Swenson L, Hare B, ... - 1yi3 (6,587 bytes)
2: ==Crystal Structure of Pim-1 bound to LY294002==
24: ...Y294002 also inhibits Pim-1, the structure of the LY294002.Pim-1 complex reveals a new binding mode that may...
26: ...echanism of serine/threonine kinase inhibition by LY294002.,Jacobs MD, Black J, Futer O, Swenson L, Hare B, ... - 1yi4 (6,547 bytes)
24: ...Y294002 also inhibits Pim-1, the structure of the LY294002.Pim-1 complex reveals a new binding mode that may...
26: ...echanism of serine/threonine kinase inhibition by LY294002.,Jacobs MD, Black J, Futer O, Swenson L, Hare B, ... - 1e8x (6,633 bytes)
24: ...nal change in the catalytic domain. Surprisingly, LY294002 and the lead compound on which it was designed, q...
26: ...osphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine.,Walker ... - Category:Ly294002 (39 bytes)
1: List of pages with the keyword Ly294002 - PI3K Activation, Inhibition, & Medical Implications (8,395 bytes)
7: ===Inhibition by Wortmannin, LY294002 & Others: Implications===
8: ...ivity leading to toxicity, neither wortmannin nor LY294002 are not valid pharmaceutical therapeutics. <ref n...
15: ===LY294002, Quercetin, Myricetin & Staurosporine===
16: ...User:David_Canner/Sandbox_P/Inhibitor_ly294002/2'>LY294002</scene> ([[1e7v]]), <scene name='User:David_Canne... - User:David Canner/Sandbox good (8,298 bytes)
27: ...User:David_Canner/Sandbox_P/Inhibitor_ly294002/2'>LY294002</scene> ([[1e7v]]), <scene name='User:David_Canne... - 4azt (4,196 bytes)
2: ...Co-crystal structure of WbdD and kinase inhibitor LY294002.== - 4cfk (3,705 bytes)
2: ==N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH LY294002==
16: ...s a new bromodomain pharmacophore and establishes LY294002 as a dual kinase and BET-bromodomain inhibitor, w...
18: The Commonly Used PI3-Kinase Probe LY294002 Is an Inhibitor of BET Bromodomains.,Dittmann A, ... - 4cfl (3,702 bytes)
16: ...s a new bromodomain pharmacophore and establishes LY294002 as a dual kinase and BET-bromodomain inhibitor, w...
18: The Commonly Used PI3-Kinase Probe LY294002 Is an Inhibitor of BET Bromodomains.,Dittmann A, ... - 6g0d (1,923 bytes)
2: ... (BD1) in complex with APSC-derived ligands (e.g. LY294002)==
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
